The new AI tool for research into treatments for Basal Cell Carcinoma
Non-invasive • Time saving
Speeding your BCC treatment research
VivoAID brings the power of artificial intelligence directly into your skin cancer research lab
Trained to automatically detect key basal cell carcinoma (BCC) image markers within VivoSight OCT scans, VivoAID presents clinically relevant findings instantly in an intuitive 3D view.
By accelerating image interpretation and highlighting areas of morphological significance, VivoAID supports confident, treatment assessment—non-invasively.
How VivoAID supports your BCC research workflow
- Supports new OCT users by guiding interpretation with automatically detected BCC image markers
- Accelerates review for experienced users by instantly highlighting marker locations
- Marker Density Histogram rapidly identifies areas of highest morphological interest
- Automated measurement of lesion volume and penetration depth
- Full 3D OCT volume rendering for comprehensive lesion assessment
- Highly cost-effective, making OCT easier to learn, faster to use, and simpler to scale
Streamline your BCC research
Scan, interpret, and assess BCCs in moments.
With VivoAID, actionable tissue assessment information is available immediately after a 15-second scan— accelerating your research.
Image markers and histogram immediately on display
Confident, rapid BCC assessment with AI support
The VivoAID algorithm has been trained on thousands of OCT images of BCCs and benign lesions.
It identifies image markers that are internationally recognised by experts as key indicators for BCC.
Following a 15-second scan, user-configurable AI image markers are displayed instantly. Regions with the highest marker density are clearly visualised, directing clinician attention to areas of greatest relevance and significantly reducing interpretation time.
The Marker Histogram identifies regions of key interest, saving time
Regulatory notice:
VivoAID is provided solely as an educational aid. It has not been cleared for clinical use and should not be used in the clinical pathway.
Interested? Schedule a Demo Today!
Our team is available for your online demo of VivoSight skin imaging. Complete the form in the link below to schedule a time with one of our experts.
Explore Further
-
Clinical Applications
Learn more about the use of VivoSight OCT in the research into new treatments for non-melanoma skin cancer (NMSC).
See VivoSight in Practice
Book an online demo with our team to see how VivoSight can support your research workflow.
